EDITORIAL
Published on 01 Jun 2023
Editorial: Circulating tumor DNA in cancer: a role as a response and monitoring “next-generation” biomarker in cancer therapy
doi 10.3389/fonc.2023.1210866
- 1,063 views
- 2 citations
- Frontiers in Oncology
- Cancer Genetics
- Research Topics
- Circulating Tumor DNA in Cancer: A Role as a Response and Monitoring “Next-Generation” Biomarker in Cancer therapy
Circulating Tumor DNA in Cancer: A Role as a Response and Monitoring “Next-Generation” Biomarker in Cancer therapy
16k
Total Downloads
62k
Total Views and Downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 26 Jan 2023
Tumor-informed or tumor-agnostic circulating tumor DNA as a biomarker for risk of recurrence in resected colorectal cancer patients
doi 10.3389/fonc.2022.1055968
- 5,365 views
- 25 citations
CASE REPORT
Published on 28 Nov 2022
Case report: Cerebrospinal fluid-derived circulating tumor DNA diagnoses and guides the treatment of a lung adenocarcinoma case with leptomeningeal metastasis
doi 10.3389/fonc.2022.944963
- 986 views
- 2 citations
REVIEW
Published on 29 Sep 2022
Clinical applications of circulating tumor-derived DNA in the management of gastrointestinal cancers – current evidence and future directions
doi 10.3389/fonc.2022.970242
- 3,611 views
- 2 citations
REVIEW
Published on 20 Jul 2022
Circulating Tumor DNA as a Cancer Biomarker: An Overview of Biological Features and Factors That may Impact on ctDNA Analysis
doi 10.3389/fonc.2022.943253
- 10,667 views
- 45 citations
ORIGINAL RESEARCH
Published on 05 Jul 2022
Circulating Tumor DNA Characteristics Based on Next Generation Sequencing and Its Correlation With Clinical Parameters in Patients With Lymphoma
doi 10.3389/fonc.2022.901547
- 1,909 views
- 2 citations
ORIGINAL RESEARCH
Published on 12 Apr 2022
Anchored Multiplex PCR Custom Melanoma Next Generation Sequencing Panel for Analysis of Circulating Tumor DNA
doi 10.3389/fonc.2022.820510
- 3,332 views
- 3 citations
ORIGINAL RESEARCH
Published on 24 Mar 2022
Genetic Characteristics Associated With Drug Resistance in Lung Cancer and Colorectal Cancer Using Whole Exome Sequencing of Cell-Free DNA
doi 10.3389/fonc.2022.843561
- 2,908 views
- 5 citations
ORIGINAL RESEARCH
Published on 22 Feb 2022
Circulating Tumor DNA Mutations in Progressive Gastrointestinal Stromal Tumors Identify Biomarkers of Treatment Resistance and Uncover Potential Therapeutic Strategies
doi 10.3389/fonc.2022.840843
- 2,749 views
- 10 citations
REVIEW
Published on 18 Nov 2021
Circulating Tumor DNA and Minimal Residual Disease (MRD) in Solid Tumors: Current Horizons and Future Perspectives
doi 10.3389/fonc.2021.763790
- 25,329 views
- 97 citations
ORIGINAL RESEARCH
Published on 11 Mar 2021
ESR1 Gene Mutation in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer Patients: Concordance Between Tumor Tissue and Circulating Tumor DNA Analysis
doi 10.3389/fonc.2021.625636
- 6,349 views
- 11 citations
Published in
Frontiers in Oncology
- Cancer Genetics
- Cancer Molecular Targets and Therapeutics
Participating Journals
Frontiers in Genetics
Cancer GeneticsOffline
- 2.8 impact factor
- 5.5 citescore
Frontiers in Pharmacology
Cancer Molecular Targets and TherapeuticsOffline
- 4.4 impact factor
- 7.8 citescore
Impact
- 62kTopic views
- 44kArticle views
- 16kArticle downloads